Luis Souhami, MD
Primary Axis:
Cancer
Email:
Email contact form Research Focus:
Research is focused in two major areas of interest: central nervous system tumors and combined chemotherapy and radiotherapy, particularly in cervix and lung cancer. Our group has also developed interest in the use of hypofractionation in the trteatment of prostate and lung cancer.Radiotherapy, combined treatment, brain tumors, lung cancer, gynecologic cancer, Genito-urinary cancer
Keywords:
Radiotherapy, combined treatment, brain tumors, lung cancer, gynecologic cancer, Genito-urinary cancer
Location:
Montreal General Hospital Publications:
Sultanem K, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, Shenouda G, Souhami L. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. International Journal of Radiation Oncology, Biology, Physics 2004; 58: 247-252.
Pearcey R, Brundage M, Drouin P, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology 2002; 20: 966-972.
Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon Jr W, Alberts DS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 2000; 18:1606-1613.
